BR9709997A - Composição em gel tópica contendo ma combinação de um nsaid e um derivado de xantina - Google Patents

Composição em gel tópica contendo ma combinação de um nsaid e um derivado de xantina

Info

Publication number
BR9709997A
BR9709997A BR9709997A BR9709997A BR9709997A BR 9709997 A BR9709997 A BR 9709997A BR 9709997 A BR9709997 A BR 9709997A BR 9709997 A BR9709997 A BR 9709997A BR 9709997 A BR9709997 A BR 9709997A
Authority
BR
Brazil
Prior art keywords
nosid
combination
composition containing
gel composition
topical gel
Prior art date
Application number
BR9709997A
Other languages
English (en)
Portuguese (pt)
Inventor
Nigel John Leeves
Francois Riahi
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9709997A publication Critical patent/BR9709997A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9709997A 1996-06-27 1997-06-24 Composição em gel tópica contendo ma combinação de um nsaid e um derivado de xantina BR9709997A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613457.2A GB9613457D0 (en) 1996-06-27 1996-06-27 Pharmaceutical compositions
PCT/US1997/011205 WO1997049405A1 (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and a xanthine derivative

Publications (1)

Publication Number Publication Date
BR9709997A true BR9709997A (pt) 1999-08-10

Family

ID=10795959

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709997A BR9709997A (pt) 1996-06-27 1997-06-24 Composição em gel tópica contendo ma combinação de um nsaid e um derivado de xantina

Country Status (14)

Country Link
EP (1) EP0973522A1 (no)
JP (1) JPH11513037A (no)
KR (1) KR20000022245A (no)
AU (1) AU3643897A (no)
BR (1) BR9709997A (no)
CA (1) CA2258199A1 (no)
CZ (1) CZ409198A3 (no)
GB (1) GB9613457D0 (no)
HU (1) HUP9903835A3 (no)
IL (1) IL127426A0 (no)
NO (1) NO986042L (no)
NZ (1) NZ333180A (no)
TR (1) TR199802701T2 (no)
WO (1) WO1997049405A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations

Also Published As

Publication number Publication date
WO1997049405A1 (en) 1997-12-31
CZ409198A3 (cs) 1999-04-14
NO986042D0 (no) 1998-12-22
CA2258199A1 (en) 1997-12-31
GB9613457D0 (en) 1996-08-28
HUP9903835A3 (en) 2001-03-28
HUP9903835A2 (hu) 2000-10-28
TR199802701T2 (xx) 1999-03-22
EP0973522A1 (en) 2000-01-26
IL127426A0 (en) 1999-10-28
AU3643897A (en) 1998-01-14
NZ333180A (en) 2000-09-29
JPH11513037A (ja) 1999-11-09
KR20000022245A (ko) 2000-04-25
NO986042L (no) 1999-02-26

Similar Documents

Publication Publication Date Title
DE69630221D1 (de) Stabile alkoholisch-wässrige zusammensetzung
BR9610156A (pt) Composição em gel
PT964849E (pt) Derivados de sulfonilureia e sua utilizacao no controlo da actovidade da interleucina-1
FI961599A (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
BR9702553A (pt) Composição cosmética e utilização
FR11C0020I2 (fr) Dérives difluoroprostaglandines et leur application
EE9900069A (et) Propioonhappe derivaadid ja nende kasutamine
DE69735712D1 (de) Aryl-pyrimidin-derivate
ATE261942T1 (de) 6-phenylpyridinderivate
DE69736582D1 (de) Uv-härtbare klebstoffzusammensetzung und gegenstand
BR9612426A (pt) Derivados carbomoilóxi e sua aplicação como antibacterianos
NO981946D0 (no) Imidazoquinazolin-derivater
BR9510229A (pt) Uso de um derivado 2-alquil ou 2-aralquil-bit e composição
PT914124E (pt) Composicao farmaceutica anti-trombotica e anti-aterogenica compreendendo um derivado de tienopiridina e um inibidor da hmg-coa-reductase
NO985227L (no) Alkylaminobenzothiazol og -benzoksazol - derivater
BR9709997A (pt) Composição em gel tópica contendo ma combinação de um nsaid e um derivado de xantina
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
ID18969A (id) Tutup untuk alat tulis
ID16838A (id) Komposisi dekafluoropentana
BR9607588A (pt) Composição aquosa de gel auto-sustentável e uso da mesma
NO983556D0 (no) Formulering og anvendelse
DE69605000D1 (de) Auftrageeinheit und Enthaarungswachsapplikator
ID17419A (id) Komposisi dekafluoropentana
NO965218D0 (no) Styre- og manövreringsstikke
BR9709277A (pt) Derivados de amidinobenzeno substituído e composições medicinais dos mesmos

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]